Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3aWXOFo
via IFTTT